Philippe Cabre: Influence Statistics

Philippe Cabre: Expert Impact

Concepts for which Philippe Cabre has direct influence: Oligoclonal bands , Radiologically isolated syndrome , Disability progression , Patients rrms , Dimethyl fumarate , Multiple sclerosis , Natalizumab fingolimod .

Philippe Cabre: KOL impact

Concepts related to the work of other authors for which for which Philippe Cabre has influence: Multiple sclerosis , Neuromyelitis optica , Zika virus , Dimethyl fumarate , Natalizumab fingolimod , Zikv infection , Patients nmosd .

KOL Resume for Philippe Cabre

Year
2016

Authors' affiliations are listed at the end of the article.

Prominent publications by Philippe Cabre

KOL-Index: 10094 . OBJECTIVE: In this study, we compared the effectiveness of teriflunomide (TRF) and dimethyl fumarate (DMF) on both clinical and MRI outcomes in patients followed prospectively in the Observatoire Français de la Sclérose en Plaques. METHODS: A total of 1,770 patients with relapsing-remitting multiple sclerosis (RRMS) (713 on TRF and 1,057 on DMF) with an available baseline brain MRI were ...
Known for Dimethyl Fumarate | Trf Dmf | Comparative Effectiveness | Multiple Sclerosis
KOL-Index: 9923 . OBJECTIVE: To compare natalizumab and fingolimod on both clinical and MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from 27 multiple sclerosis centers participating in the French follow-up cohort Observatoire of Multiple Sclerosis. METHODS: Patients with RRMS included in the study were aged from 18 to 65 years with an Expanded Disability Status Scale score of ...
Known for Natalizumab Fingolimod | Patients Rrms | Year Treatment | Comparative Efficacy
KOL-Index: 8482 . Background: Guillain-Barré syndrome (GBS) has been reported to be associated with Zika virus (ZIKV) infection in case reports and retrospective studies, mostly on the basis of serological tests, with the problematic cross-reacting antibodies of the Flavivirus genus. Some GBS cases do not exhibit a high level of diagnostic certainty. This prospective study aimed to describe the clinical ...
Known for Zika Virus | Zikv Infection | Gbs Cases | Barré Syndrome
KOL-Index: 4613 . Neuromyelitis optica (NMO) (and NMO spectrum disorder) is an autoimmune inflammatory disease of the CNS primarily affecting spinal cord and optic nerves. Reliable and sensitive biomarkers for onset, relapse, and progression in NMO are urgently needed because of the heterogeneous clinical presentation, severity of neurologic disability following relapses, and variability of therapeutic ...
Known for Neuromyelitis Optica | Spinal Cord | Optic Nerves | Seropositive Nmo
KOL-Index: 4467 . Background: Steps towards the development of diagnostic criteria are needed for children with the radiologically isolated syndrome to identify children at risk of clinical demyelination. Objectives: To evaluate the 2005 and 2016 MAGNIMS magnetic resonance imaging criteria for dissemination in space for multiple sclerosis, both alone and with oligoclonal bands in cerebrospinal fluid added, ...
Known for Oligoclonal Bands | Radiologically Isolated Syndrome | Multiple Sclerosis | Clinical Event
KOL-Index: 3717 . Multiple sclerosis (MS) disease risk is associated with reduced sun-exposure. This study assessed the relationship between measures of sun exposure (vitamin D [vitD], latitude) and MS severity in the setting of two multicenter cohort studies (n NationMS = 946, n BIONAT = 990). Additionally, effect-modification by medication and photosensitivity-associated MC1R variants was assessed. High ...
Known for Multiple Sclerosis | Sun Exposure | Immune Cells | Immunomodulatory Effects
KOL-Index: 3503 . In multiple sclerosis, treatment start or switch is prompted by evidence of disease activity. Whilst immunomodulatory therapies reduce disease activity, the time required to attain maximal effect is unclear. In this study we aimed to develop a method that allows identification of the time to manifest fully and clinically the effect of multiple sclerosis treatments ('therapeutic lag') on ...
Known for Multiple Sclerosis | Therapeutic Lag | Disability Progression | Treatment Disease

Key People For Oligoclonal Bands

Top KOLs in the world
#1
Hans Link
multiple sclerosis myasthenia gravis dendritic cells
#2
Wallace W Tourtellotte
multiple sclerosis cerebrospinal fluid situ hybridization
#3
Alanda K Thompson
multiple sclerosis spinal cord magnetic resonance
#4
Hans‐Peter Hartung
multiple sclerosis chronic inflammatory schwann cells
#5
Fred D Lublin
multiple sclerosis glatiramer acetate monoclonal antibodies
#6
Sten Öhman
multiple sclerosis cerebrospinal fluid ionized calcium

Authors' affiliations are listed at the end of the article.